Recent Updates
Recently added Catalysts
CELC Positive Sentiment

Celcuity To Participate in Jefferies Global Healthcare Conference

Monday, June 3, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Celcuity Inc. announced its participation in the upcoming Jefferies Global Healthcare Conference set to take place in New York from June 4 to June 6, 2024. CEO Brian Sullivan will engage in a fireside chat on June 6 at 10:00 a.m. ET. The event can be followed live via a webcast, further promoting the company’s focus on oncology therapies.
Price reaction · baseline $15.8 (2024-05-31 close) · clean, no other CELC news in the window
day 0 close
-5.3%
day 1
-6.1%
day 3 · peak
-9.2%

Conference Participation Details

Jefferies Global Healthcare Conference
Date: November 18, 2025
Time: 11:30 a.m. GMT / 6:30 a.m. ET
Location: London
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Celcuity is actively participating in a significant healthcare conference.
  • The event provides visibility for Celcuity and its oncology targeted therapies.
  • Brian Sullivan's planned participation may enhance investor confidence.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+27%
120-day peak, hindsight
Typical move
14.9%
average across 6 past catalysts
Cash runway
~41 mo
Minimal dilution risk
Lead asset
Gedatolisib
Phase 3 · Breast Cancer

Full Press Release Details

MINNEAPOLIS, June 03, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies Global Healthcare Conference to be held in New York on June 4-6, 2024.
Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, is scheduled for a fireside chat at 10:00 a.m. ET on Thursday, June 6, 2024. A live webcast of the event will be available using this weblink https://wsw.com/webcast/jeff302/celc/1809904. Alternatively, the live webcast will be accessible from the Investors section of the company's website at https://ir.celcuity.com/events-presentations/ with a replay available shortly after.
View source version of release on GlobeNewswire.com

Frequently Asked Questions

When is Celcuity participating in the Jefferies Conference?

Celcuity is participating in the Jefferies Global Healthcare Conference on June 4-6, 2024.

Who will represent Celcuity at the conference?

Brian Sullivan, CEO and Co-founder of Celcuity, will represent the company.

What time is Brian Sullivan's chat during the conference?

Brian Sullivan's fireside chat is scheduled for 10:00 a.m. ET on June 6, 2024.

Where can I watch the live webcast of the event?

The live webcast can be accessed at https://wsw.com/webcast/jeff302/celc/1809904.

Will a replay of the conference be available?

Yes, a replay will be available shortly after the event on their website.

ShareAdd on Google
Tags: CELC Viatris Investor Conferences Healthcare Celcuity Jefferies Global Healthcare Conference oncology Brian Sullivan clinical-stage biotechnology
Last updated: Jun 3, 2024

Conference Timeline

Nov 11, 2025
UBS Global Healthcare Conference
8:45 AM ET • Fireside Chat
Nov 18, 2025
Jefferies Global Healthcare
11:30 AM GMT • London

Biotech snapshot

Cash runway
$754M liquidity · $18M/mo burn
~41 mo
Minimal dilution risk
Lead asset
GedatolisibPhase 3
Breast Cancer →

Catalyst track record

+27%
best trade around CELC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CELC.

See every catalyst's timing & PoA →